BioSpace News Archive

Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to discover breakthrough medicines for patients, today announced the company will present preclinical data demonstrating that oral daily dosing of its IRAK4 degraders completely suppressed IRAK4 protein expression in skin and immune cells and inhibited cutaneous inflammation.

Biocoat, Inc., a specialty manufacturer of hydrophilic biomaterial coatings for medical devices, today announced the launch of HYDAK® UV.

Infiniti Research is a leading provider of market intelligence services to businesses around the globe.

SOUTH SAN FRANCISCO, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading, off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today named Kristin Yarema as Chief Commercial Officer, effective as of February 18, 2020. Dr. Yarema has more than 20 years of biopharmaceutical experience during which she has led product strategy and commercialization for therapies at a

Feb. 5, 2020 14:00 UTC Glucagon Emergency Kit is a cost-effective alternative to currently marketed branded kit products for severe hypoglycemia

Life Image, the world’s largest medical evidence network for clinical and imaging data, announced a new enterprise solution to help healthcare companies establish large scale, imaging- and data-intensive networks to coordinate and deliver care, collaborate and innovate.

As the leading authority on children’s oral health, the American Academy of Pediatric Dentistry is a proud and strong supporter of this month.

Feb. 5, 2020 16:30 UTC Blood Test Accurately Identifies HPV-related Head and Neck Cancer Recurrence; Prospective Clinical Study Published in Journal of Clinical Oncology Naveris, Inc. to provide NavDx ® blood test to Cancer Centers of Excellence WALTHAM, Mass.--( BUSINESS WIRE )-- A novel blood test can detect recurrent Human Papilloma Virus (HPV)-related head and neck (oropharyngeal) cancers, according to a study published online in the Journal of Clinical Oncology b

Providence expanding telebehavioral health concierge service to increase convenient access to mental health providers for the 119,000 doctors, nurses, employees and their dependents at its seven state family of organizations

Funding enables expansion of clinical program to include additional cancer indications and development of a capsule formulation of MaaT Pharma’s full-ecosystem therapeutic